Clinical Trial: Lifestyle Intervention for Type 2 Diabetes in Primary Care (CREDOenAP)

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07207980) titled 'Lifestyle Intervention for Type 2 Diabetes in Primary Care (CREDOenAP)' on Sept. 16.

Brief Summary: The purpose of this clinical trial is to determine whether an intensive lifestyle intervention can achieve remission of type 2 diabetes mellitus (T2DM) in adult patients treated in primary care. The main questions the study seeks to answer are:

* What proportion of participants achieve diabetes remission after 6 months of intervention?

* How many participants maintain remission 12 months after completing the program (18 months total)?

Participants will:

* Follow a personalized dietary plan with carbohydrate restriction.

* Engage i...